title: Immunoglobulin therapy in idiopathic hypothalamic dysfunction.
abstract: Idiopathic hypothalamic dysfunction is a rare disorder presenting at age 3-7 years. Severe hypothalamic and brainstem dysfunction leads to death in 25% of patients. The disease is presumed to be autoimmune, or in some cases paraneoplastic. No successful treatment has been reported. Patient V. developed hyperphagia, hypersomnia, and extreme aggression at age 7 years, accompanied by episodes of hyperthermia, hypothermia, sinus bradycardia, hypernatremia, hyponatremia, persistent hyperprolactinemia, hypothyroidism, and growth-hormone deficiency. At age 9 years, a diagnosis of idiopathic hypothalamic dysfunction was rendered, and immunoglobulin therapy was commenced. Nine courses of immunoglobulins, at a dose of 2 g/kg every 4 weeks, were administered. Reproducible improvements in behavior and no further episodes of hyponatremia or hypernatremia and sinus bradycardia were evident. The endocrinologic abnormalities and poor thermoregulation remained. Administration of immunoglobulins during late stages of idiopathic hypothalamic dysfunction led to improvement in some but not all signs. Assuming an autoimmune basis for this disorder, treatment during early stages of disease should be more effective. To facilitate such early treatment, increased awareness of this disorder is necessary, to allow for early diagnosis.
authors: Department of Pediatrics and Pediatric Neurology, Georg August University, Robert-Koch-Strasse 40, Göttingen D-37075, Germany. phuppke@med.uni-goettingen.de
authors: Peter
authors: P
authors: Huppke
authors: Alexander
authors: A
authors: Heise
authors: Kevin
authors: K
authors: Rostasy
authors: Brenda
authors: B
authors: Huppke
authors: Jutta
authors: J
authors: Gärtner
mesh_terms: D001921:Brain / Q000473:pathology; D002648:Child; D042241:Early Diagnosis; D006801:Humans; D007027:Hypothalamic Diseases / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000008:administration & dosage*; D008279:Magnetic Resonance Imaging; D016896:Treatment Outcome
chemical_list: D007136:Immunoglobulins